Erste Asset Management’s Autolus Therapeutics AUTL Stock Holding History

Erste Asset Management’s Portfolio AUTL Stock Details AUTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$322K	Hold	195,000	–	–	﹤0.01%	544
2026 Q1	$248K	Hold	195,000	–	–	﹤0.01%	559
2025 Q4	$365K	Hold	195,000	–	–	﹤0.01%	529
2025 Q3	$310K	Hold	195,000	–	–	﹤0.01%	529
2025 Q2	$450K	Hold	195,000	–	–	﹤0.01%	646
2025 Q1	$324K	Hold	195,000	–	–	﹤0.01%	453
2024 Q4	$441K	Hold	195,000	–	–	0.01%	449
2024 Q3	$708K	Hold	195,000	–	–	0.01%	406
2024 Q2	$649K	Hold	195,000	–	–	0.01%	402
2024 Q1	$1.22M	Hold	195,000	–	–	0.02%	355
2023 Q4	$1.29M	Hold	195,000	–	–	0.02%	353
2023 Q3	$470K	Hold	195,000	–	–	0.01%	414
2023 Q2	$445K	Hold	195,000	–	–	0.01%	425
2023 Q1	$343K	Hold	195,000	–	–	0.01%	460
2022 Q4	$353K	Buy	195,000 +75,000	+63%	+$190K	0.01%	449
2022 Q3	$268K	Hold	120,000	–	–	0.01%	477
2022 Q2	$340K	Hold	120,000	–	–	0.01%	466
2022 Q1	$508K	Hold	120,000	–	–	0.01%	434
2021 Q4	$612K	Hold	120,000	–	–	0.01%	410
2021 Q3	$761K	Hold	120,000	–	–	0.02%	363
2021 Q2	$785K	Hold	120,000	–	–	0.02%	369
2021 Q1	$659K	Buy	+120,000	New	+$888K	0.02%	365

Other funds holding AUTL

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Erste Asset Management's AUTL Position: Q2 2026 in Review

Erste Asset Management held its Autolus Therapeutics (AUTL) position steady in Q2 2026 at 195,000 shares worth $322K. The position accounts for ﹤0.01% of the portfolio, ranked #544.

Erste Asset Management first reported a position in AUTL in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.29M in Q4 2023. 84 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

Erste Asset Management held 195,000 shares of Autolus Therapeutics worth $322K as of Q2 2026.
Erste Asset Management left its Autolus Therapeutics share count unchanged in Q2 2026.
Autolus Therapeutics made up ﹤0.01% of Erste Asset Management's portfolio in Q2 2026, its #544 holding.
Erste Asset Management first reported a position in Autolus Therapeutics in Q1 2021 and has held it in 22 quarters since.
Erste Asset Management's Autolus Therapeutics position peaked at $1.29M in Q4 2023.
84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.